These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21570203

  • 1. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW, Seong J, Yun M, Lee IJ, Yoon HI, Cho HJ, Han KH.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1172-8. PubMed ID: 21570203
    [Abstract] [Full Text] [Related]

  • 2. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Kim BK, Kang WJ, Kim JK, Seong J, Park JY, Kim DY, Ahn SH, Lee DY, Lee KH, Lee JD, Han KH.
    Cancer; 2011 Oct 15; 117(20):4779-87. PubMed ID: 21469082
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
    Kim MJ, Kim YS, Cho YH, Jang HY, Song JY, Lee SH, Jeong SW, Kim SG, Jang JY, Kim HS, Kim BS, Lee WH, Park JM, Lee JM, Lee MH, Choi DL.
    Korean J Intern Med; 2015 May 15; 30(3):308-15. PubMed ID: 25995661
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY, Kao CH, Huang WS, Chen CM, Chang LP, Lee MS, Chao HL, Chiu CH, Lo CH, Jen YM.
    J Nucl Med; 2013 Oct 15; 54(10):1710-6. PubMed ID: 23970365
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
    Song MJ, Bae SH, Yoo IeR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK.
    World J Gastroenterol; 2012 Jul 07; 18(25):3215-22. PubMed ID: 22783045
    [Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
    Cho E, Jun CH, Kim BS, Son DJ, Choi WS, Choi SK.
    Turk J Gastroenterol; 2015 Jul 07; 26(4):344-50. PubMed ID: 26039005
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma.
    Choi SH, Chang JS, Jeong YH, Lee Y, Yun M, Seong J.
    Liver Int; 2014 Aug 07; 34(7):1118-25. PubMed ID: 24528941
    [Abstract] [Full Text] [Related]

  • 10. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
    Lee JW, Oh JK, Chung YA, Na SJ, Hyun SH, Hong IK, Eo JS, Song BI, Kim TS, Kim DY, Kim SU, Moon DH, Lee JD, Yun M.
    J Nucl Med; 2016 Apr 07; 57(4):509-16. PubMed ID: 26742711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
    Cascales-Campos PA, Ramírez P, Lopez V, Gonzalez R, Saenz-Mateos L, Llacer E, Sánchez Bueno F, Robles R, Pons JA, Capel A, Frutos L, Navarro JL, Muñoz-Ramon P, Parrilla P.
    Transplant Proc; 2015 Oct 07; 47(8):2374-6. PubMed ID: 26518931
    [Abstract] [Full Text] [Related]

  • 13. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
    Song HJ, Cheng JY, Hu SL, Zhang GY, Fu Y, Zhang YJ.
    Clin Radiol; 2015 Feb 07; 70(2):128-37. PubMed ID: 25459673
    [Abstract] [Full Text] [Related]

  • 14. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
    Hatano E, Ikai I, Higashi T, Teramukai S, Torizuka T, Saga T, Fujii H, Shimahara Y.
    World J Surg; 2006 Sep 07; 30(9):1736-41. PubMed ID: 16850145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, Steinmetz A, Sosna J, Groshar D.
    Radiology; 2011 Aug 07; 260(2):503-10. PubMed ID: 21555347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.
    Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Kubo S, Ochi H.
    Am J Gastroenterol; 2001 Jun 07; 96(6):1877-80. PubMed ID: 11419843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.